Screening of circulating microRNA biomarkers for prevalence of abdominal aortic aneurysm and aneurysm growth

Atherosclerosis

Volumn 256, Issue , 2017, Pages 82-88

  Wanhainen, Anders ^a   Mani, Kevin ^a   Vorkapic, Emina ^b   De Basso, Rachel ^c,d   Björck, Martin ^a   Länne, Toste ^b   Wågsäter, Dick ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c Division of Medical Diagnostics   (Sweden)

^d JÖNKÖPING UNIVERSITY   (Sweden)

Author keywords

Aneurysm; Biomarker; MicroRNA; Plasma; Risk factor

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 10B; MICRORNA 125A; MICRORNA 136; MICRORNA 16; MICRORNA 192; MICRORNA 194; MICRORNA 195; MICRORNA 205; MICRORNA 215; MICRORNA 221; MICRORNA 223; MICRORNA 30A; MICRORNA 326; MICRORNA 331; MICRORNA 335; MICRORNA 33A; MICRORNA 421; MICRORNA 652; MICRORNA 99A; UNCLASSIFIED DRUG; GENETIC MARKER;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; FOLLOW UP; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PLASMA; POPULATION BASED CASE CONTROL STUDY; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; AORTIC ANEURYSM, ABDOMINAL; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; DIAGNOSTIC IMAGING; FEMALE; GENETIC MARKER; GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWEDEN; TIME FACTOR;

AGED; AORTIC ANEURYSM, ABDOMINAL; AREA UNDER CURVE; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENETIC MARKERS; HUMANS; MALE; MICRORNAS; PREDICTIVE VALUE OF TESTS; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; SWEDEN; TIME FACTORS;

EID: 85008191091     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.11.007     Document Type: Article

References (20)

1. [1] Thompson, S.G., Brown, L.C., Sweeting, M.J., Bown, M.J., Kim, L.G., Glover, M.J., Buxton, M.J., Powell, J.T., Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness. Health Technol. Assess. 17 (2013), 1–118.
2. [2] Moll, F.L., Powell, J.T., Fraedrich, G., Verzini, F., Haulon, S., Waltham, M., van Herwaarden, J.A., Holt, P.J., van Keulen, J.W., Rantner, B., Schlosser, F.J., Setacci, F., Ricco, J.B., European Society for Vascular S. Management of abdominal aortic aneurysms clinical practice guidelines of the european society for vascular surgery. Eur. J. Vasc. Endovasc. Surg. 41:Suppl 1 (2011), S1–S58.
3. [3] International, A.A.A.S.G., Bjorck, M., Bown, M.J., Choke, E., Earnshaw, J., Florenes, T., Glover, M., Kay, M., Laukontaus, S., Lees, T., Lindholt, J., Powell, J.T., van Rij, A., Svensjo, S., Wanhainen, A., International update on screening for abdominal aortic aneurysms: issues and opportunities. Eur. J. Vasc. Endovasc. Surg. 49 (2015), 113–115.
4. [4] Biros, E., Moran, C.S., Wang, Y., Walker, P.J., Cardinal, J., Golledge, J., Microrna profiling in patients with abdominal aortic aneurysms: the significance of mir-155. Clin. Sci. (Lond.) 126 (2014), 795–803.
5. [5] Stather, P.W., Sylvius, N., Sidloff, D.A., Dattani, N., Verissimo, A., Wild, J.B., Butt, H.Z., Choke, E., Sayers, R.D., Bown, M.J., Identification of micrornas associated with abdominal aortic aneurysms and peripheral arterial disease. Br. J. Surg. 102 (2015), 755–766.
6. [6] Zhang, W., Shang, T., Huang, C., Yu, T., Liu, C., Qiao, T., Huang, D., Liu, Z., Liu, C., Plasma micrornas serve as potential biomarkers for abdominal aortic aneurysm. Clin. Biochem. 48 (2015), 988–992.
7. [7] Kin, K., Miyagawa, S., Fukushima, S., Shirakawa, Y., Torikai, K., Shimamura, K., Daimon, T., Kawahara, Y., Kuratani, T., Sawa, Y., Tissue- and plasma-specific microrna signatures for atherosclerotic abdominal aortic aneurysm. J. Am. Heart Assoc., 1, 2012, e000745.
8. [8] Maegdefessel, L., Spin, J.M., Raaz, U., Eken, S.M., Toh, R., Azuma, J., Adam, M., Nakagami, F., Heymann, H.M., Chernogubova, E., Jin, H., Roy, J., Hultgren, R., Caidahl, K., Schrepfer, S., Hamsten, A., Eriksson, P., McConnell, M.V., Dalman, R.L., Tsao, P.S., Mir-24 limits aortic vascular inflammation and murine abdominal aneurysm development. Nat. Commun., 5, 2014, 5214.
9. [9] Krek, A., Grun, D., Poy, M.N., Wolf, R., Rosenberg, L., Epstein, E.J., MacMenamin, P., da Piedade, I., Gunsalus, K.C., Stoffel, M., Rajewsky, N., Combinatorial microrna target predictions. Nat. Genet. 37 (2005), 495–500.
10. [10] Huang da, W., Sherman, B.T., Lempicki, R.A., Systematic and integrative analysis of large gene lists using david bioinformatics resources. Nat. Protoc. 4 (2009), 44–57.
11. [11] Matsumoto, S., Sakata, Y., Suna, S., Nakatani, D., Usami, M., Hara, M., Kitamura, T., Hamasaki, T., Nanto, S., Kawahara, Y., Komuro, I., Circulating p53-responsive micrornas are predictive indicators of heart failure after acute myocardial infarction. Circ. Res. 113 (2013), 322–326.
12. [12] Li, P., Zhang, Q., Wu, X., Yang, X., Zhang, Y., Li, Y., Jiang, F., Circulating micrornas serve as novel biological markers for intracranial aneurysms. J. Am. Heart Assoc., 3, 2014, e000972.
13. [13] Yu, X., Li, Z., Chen, G., Wu, W.K., Microrna-10b induces vascular muscle cell proliferation through akt pathway by targeting tip30. Curr. Vasc. Pharmacol. 13 (2015), 679–686.
14. [14] Spear, R., Boytard, L., Blervaque, R., Chwastyniak, M., Hot, D., Vanhoutte, J., Staels, B., Lemoine, Y., Lamblin, N., Pruvot, F.R., Haulon, S., Amouyel, P., Pinet, F., Adventitial tertiary lymphoid organs as potential source of microrna biomarkers for abdominal aortic aneurysm. Int. J. Mol. Sci. 16 (2015), 11276–11293.
15. [15] Raffort, J., Lareyre, F., Clement, M., Mallat, Z., Micro-rnas in abdominal aortic aneurysms: insights from animal models and relevance to human disease. Cardiovasc. Res. 110:2 (2016), 165–177.
16. [16] Pafili, K., Gouni-Berthold, I., Papanas, N., Mikhailidis, D.P., Abdominal aortic aneurysms and diabetes mellitus. J. Diabetes Complicat. 29 (2015), 1330–1336.
17. [17] Brady, A.R., Thompson, S.G., Fowkes, F.G., Greenhalgh, R.M., Powell, J.T., Participants UKSAT. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 110 (2004), 16–21.
18. [18] Li, D., Yang, P., Xiong, Q., Song, X., Yang, X., Liu, L., Yuan, W., Rui, Y.C., Microrna-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells. J. Hypertens. 28 (2010), 1646–1654.
19. [19] Che, P., Liu, J., Shan, Z., Wu, R., Yao, C., Cui, J., Zhu, X., Wang, J., Burnett, M.S., Wang, S., Wang, J., Mir-125a-5p impairs endothelial cell angiogenesis in aging mice via rtef-1 downregulation. Aging Cell 13 (2014), 926–934.
20. [20] Oger, F., Gheeraert, C., Mogilenko, D., Benomar, Y., Molendi-Coste, O., Bouchaert, E., Caron, S., Dombrowicz, D., Pattou, F., Duez, H., Eeckhoute, J., Staels, B., Lefebvre, P., Cell-specific dysregulation of microrna expression in obese white adipose tissue. J. Clin. Endocrinol. Metab. 99 (2014), 2821–2833.